Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS).

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cold Spring Harbor Perspectives in Medicine

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/cshperspect.a024117PMID 28003278PMCID PMC5538408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy.

  2017influential reference
• Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?

  2015cited by this paper
• From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.

  2015influential reference
• From nucleation to widespread propagation: A prion-like concept for ALS.

  2015cited by this paper
• Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis.

  2014cited by this paper
• Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms

  2014cited by this paper
• Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis

  2014influential reference
• TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

  2014cited by this paper
• State of play in amyotrophic lateral sclerosis genetics

  2013cited by this paper
• Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis

  2013cited by this paper
• Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.

  2013influential reference
• Spreading of amyotrophic lateral sclerosis lesions—multifocal hits and local propagation?

  2013influential reference
• Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review

  2013cited by this paper
• Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

  2013cited by this paper
• The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS

  2013influential reference
• RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia

  2013influential reference
• Amyotrophic lateral sclerosis—a model of corticofugal axonal spread

  2013cited by this paper
• Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

  2013cited by this paper
• Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

  2013influential reference
• C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

  2013cited by this paper
• Young-onset amyotrophic lateral sclerosis: historical and other observations.

  2012cited by this paper
• Primary lateral sclerosis: Upper‐motor‐predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration – immunohistochemical and biochemical analyses of TDP‐43

  2012cited by this paper
• Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p

  2012cited by this paper
• Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis

  2012influential reference
• The genetics and neuropathology of frontotemporal lobar degeneration

  2012cited by this paper
• Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?

  2012influential reference
• An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62‐positive, TDP‐43‐negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline

  2012cited by this paper
• Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis

  2012cited by this paper
• Predicting regional neurodegeneration from the healthy brain functional connectome.

  2012cited by this paper
• Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Glial Cells in Amyotrophic Lateral Sclerosis

  2011cited by this paper
• Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study

  2011cited by this paper
• p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS

  2011cited by this paper
• Leading Edge Perspective The Seeds of Neurodegeneration : Prion-like Spreading in ALS

  2011cited by this paper
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia

  2011cited by this paper
• Patterns of cortical activity differ in ALS patients with limb and/or bulbar involvement depending on motor tasks

  2011cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.

  2011cited by this paper
• Energy metabolism in amyotrophic lateral sclerosis.

  2011cited by this paper
• Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS

  2011cited by this paper
• Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy

  2011influential reference
• Neuropsychological Functioning in PLS: A Comparison with ALS

  2011cited by this paper
• Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit

  2011cited by this paper
• What Are the Different Initial Presentations of Frontotemporal Dementia?

  2011cited by this paper
• Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis

  2011cited by this paper
• Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases

  2010cited by this paper
• Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients

  2010cited by this paper
• Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

  2010cited by this paper
• Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS

  2010cited by this paper
• Extensive FUS‐Immunoreactive Pathology in Juvenile Amyotrophic Lateral Sclerosis with Basophilic Inclusions

  2010cited by this paper
• Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy

  2010cited by this paper
• Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss

  2010cited by this paper
• STUDY OF 962 PATIENTS INDICATES PROGRESSIVE MUSCULAR ATROPHY IS A FORM OF ALS

  2010cited by this paper
• The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.

  2010cited by this paper
• ALS motor phenotype heterogeneity, focality, and spread

  2009cited by this paper
• TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea

  2009cited by this paper
• Neurodegenerative diseases target large-scale human brain networks.

  2009cited by this paper
• Natural history and clinical features of the flail arm and flail leg ALS variants

  2009cited by this paper
• Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology.

  2009cited by this paper
• Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALS

  2009cited by this paper
• Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

  2009cited by this paper
• Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups

  2009cited by this paper
• Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review.

  2009cited by this paper
• Transcranial magnetic stimulation in ALS

  2009cited by this paper
• Incidence of amyotrophic lateral sclerosis in Europe

  2009influential reference
• Updates on amyotrophic lateral sclerosis: Improving patient care

  2009cited by this paper
• Study of 962 patients indicates progressive muscular atrophy is a form of ALS

  2009cited by this paper
• Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.

  2008cited by this paper
• Selective functional, regional, and neuronal vulnerability in frontotemporal dementia

  2008cited by this paper
• Adult-onset sporadic progressive muscular atrophy : natural history, diagnosis, and prognostic factors

  2008cited by this paper
• Chorea‐ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic, and neuropathological study

  2008cited by this paper
• Implications of ALS focality

  2007cited by this paper
• Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.

  2007cited by this paper
• Primary lateral sclerosis

  2007cited by this paper
• Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.

  2007cited by this paper
• Focality of upper and lower motor neuron degeneration at the clinical onset of ALS

  2007influential reference
• Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

  2007cited by this paper
• Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters

  2006cited by this paper
• Review ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

  2006cited by this paper
• The natural history of primary lateral sclerosis

  2006cited by this paper
• TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

  2006influential reference
• Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

  2006cited by this paper
• ALS: a disease of motor neurons and their nonneuronal neighbors.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006influential reference
• Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET

  2005cited by this paper
• Primary Lateral Sclerosis: Clinical and Laboratory Features in 25 Patients

  2005cited by this paper
• Hemiplegic ALS

  2005cited by this paper
• The effects of executive and behavioral dysfunction on the course of ALS

  2005cited by this paper
• Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS)

  2004cited by this paper
• Amyotrophic lateral sclerosis with dementia: The clinicopathological spectrum

  2004cited by this paper
• Cortical selective vulnerability in motor neuron disease: a morphometric study.

  2004cited by this paper
• Degeneration of betz cells in motor neuron disease. A Golgi study

  2004cited by this paper
• Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS)

  2004cited by this paper
• Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

  2003cited by this paper
• Primary lateral sclerosis

  2003cited by this paper
• Are amyotrophic lateral sclerosis patients cognitively normal?

  2003cited by this paper
• Association of chorea and motor neuron disease

  2002cited by this paper

• Genetic commonalities between rare subtypes of ALS and CMT: insights into molecular mechanisms of neurodegeneration

  2026cites this paper
• Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.

  2026cites this paper
• Mechanisms and Therapeutic Potential of Stem Cell‐Derived Extracellular Vesicles as Nanocarriers in Musculoskeletal Disorders

  2026cites this paper
• Tailoring treatments: pharmacogenomics in the management of neurodegenerative diseases.

  2026cites this paper
• Neuroinflammaging and Sex-Specific Mechanisms: Biomarker Discovery and Emerging Technological Approaches in Aging Brain Disorders

  2026cites this paper
• Voxel-mirrored homotopic connectivity in upper motor neuron-dominant amyotrophic lateral sclerosis is associated with different spread directions

  2026cites this paper
• Impacts of Muscle Enzyme Levels on Progression and Survival in ALS Population: A Cohort Study and Meta‐Analysis

  2026cites this paper
• The Calcium Connection: Explaining Motor Neuron Vulnerability in ALS.

  2026cites this paper
• Safety and efficacy of the Atalante exoskeleton in the rehabilitation of French patients with amyotrophic lateral sclerosis: a prospective, monocentric, open, uncontrolled, interventional protocol, EXALS

  2026cites this paper
• A population based study to analyse amyotrophic lateral sclerosis as a multi-step process

  2025cites this paper
• Establishing Diagnostic and Differential Diagnostic Criteria for Amyotrophic Lateral Sclerosis

  2025cites this paper
• Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in China

  2025cites this paper
• Early Dropped Head Syndrome Is More Prevalent in C9orf72 and FUS/TLS ALS

  2025cites this paper
• Microglia in ALS: Insights into Mechanisms and Therapeutic Potential

  2025cites this paper
• Structural Insights into the Dynamics of Water in SOD1 Catalysis and Drug Interactions

  2025cites this paper
• Clinical and Paraclinical Predictors of Survival in Amyotrophic Lateral Sclerosis: Results from a Three-Year Longitudinal Cohort Study

  2025cites this paper
• Muscle Matters: Transforming Amyotrophic Lateral Sclerosis Diagnostics with Next-Gen Biosensors and Smart Detection.

  2025cites this paper
• T1-relaxation times along the corticospinal tract as a diagnostic marker in patients with amyotrophic lateral sclerosis

  2025cites this paper
• A role for the spinal cord cholinergic neuron circadian clock in RNA metabolism and mediating ALS disease phenotypes

  2025cites this paper
• Black chokeberry (×Sorbaronia mitschurinii) fruit extract affects the survival of Drosophila melanogaster with the model of amyotrophic lateral sclerosis depending on the concentration

  2025cites this paper
• Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses

  2025cites this paper
• Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration

  2025cites this paper
• CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects

  2025cites this paper
• Differentiating upper- and lower motor neuron diseases using automated acoustic analysis

  2025cites this paper
• Case Report: A case of ALS type 6 associated with a FUS gene variant and right limb muscle weakness and atrophy as the initial symptom

  2025cites this paper
• Innovative Synchronous Spectrofluorometric Method for Assessing a Novel Drug Combination in Amyotrophic Lateral Sclerosis: In Vivo Human Application With Greenness and Sustainability Evaluation

  2025cites this paper
• The impact of obstructive sleep apnea and the prognostic role of level III polysomnography at the onset of amyotrophic lateral sclerosis

  2025cites this paper
• HomeSenseALS: A Mobile Sensing and Self-Monitoring System to Monitor Patients with ALS in Everyday Life

  2025cites this paper
• Comprehensive identification of pathogenic tandem repeat expansions in sporadic amyotrophic lateral sclerosis: advantages of long-read vs. short-read sequencing

  2025cites this paper
• Early assessment in bulbar-onset amyotrophic lateral sclerosis detects similar rates of nocturnal desaturation and orthopnoea compared to non-bulbar-onset disease

  2025cites this paper
• Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration

  2025cites this paper
• Hidden players in the metabolic vulnerabilities of amyotrophic lateral sclerosis.

  2025cites this paper
• Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy

  2025cites this paper
• A Comprehensive Overview of Neurophysiological Correlates of Cognitive Impairment in Amyotrophic Lateral Sclerosis

  2025cites this paper
• Seed Amplification Assays as Powerful Tools for Detecting Peripheral Biomarkers in Prion-Like Diseases.

  2025cites this paper
• A role for the cholinergic neuron circadian clock in RNA metabolism and mediating neurodegeneration

  2025cites this paper
• Monoaminergic Alterations at the Subregional Cervical and Thoracic Spinal Cord Level of Patients Within the FTD‐ALS Continuum and Early‐Onset AD: Low Thoracic Dopaminergic Activity in ALS

  2025cites this paper
• Ferroptosis in neurodegenerative diseases: mechanisms and therapeutic potential of stem cell derivatives

  2025cites this paper
• Unravelling the role of protein kinase R (PKR) in neurodegenerative disease: a review

  2025cites this paper
• Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis

  2025cites this paper
• Unveiling structural damage of the corpus callosum in amyotrophic lateral sclerosis through diffusion tensor imaging and spread direction perspectives

  2025cites this paper
• Advanced 3D biomaterials and bioprinting strategies for in vitro modeling of neurodegenerative diseases

  2025cites this paper
• The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations

  2025cites this paper
• Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics

  2025cites this paper
• Excitatory Amino Acid Transporters as Therapeutic Targets in the Treatment of Neurological Disorders: Their Roles and Therapeutic Prospects

  2025cites this paper
• Analysis of a Novel Training Game with Eye Tracking and Electromyography for Autonomous Wheelchair Control

  2025cites this paper
• A Novel Genetic TDP‐43 Pig Model Mimics Multiple Key ALS‐Like Features

  2025cites this paper
• Rethinking ALS: Current understanding and emerging therapeutic strategies

  2025cites this paper
• Demyelinating Disorders in the Spinal Cord of Transgenic mSOD1 Mice as One of the Mechanisms of Amyotrophic Lateral Sclerosis Pathogenesis

  2025cites this paper
• Findings from transcriptomics and immunohistochemistry indicate an autoimmune disease targeting brainstem inhibitory interneurons in bovine spastic paresis

  2025cites this paper
• Mitochondrial respiratory complex IV deficiency recapitulates amyotrophic lateral sclerosis

  2025cites this paper
• Analysis of retinal markers and incident amyotrophic lateral sclerosis: An optical coherence tomography-based cohort study

  2025cites this paper
• Diagnostic role of circulating cell-free DNA in schizophrenia and neuro-degenerative disorders.

  2025cites this paper
• Microbial Production of Nicotinamide Mononucleotide: Key Enzymes Discovery, Host Cells Selection, and Pathways Design and Optimization.

  2025cites this paper
• Assessment of social cognition in patients with amyotrophic lateral sclerosis: protocol for a cross-sectional comparative study at Angers University Hospital

  2025cites this paper
• The Regulation of TDP-43 Structure and Phase Transitions: A Review

  2025cites this paper
• An ALS assembly modulator signature in peripheral blood mononuclear cells: implications for ALS pathophysiology, therapeutics, and diagnostics

  2025cites this paper
• TIA1-mediated stress granules promote neurodegeneration by sequestering HSP70 mRNA in C9orf72 mice.

  2025cites this paper
• Meta-Analysis of Gene Expression in Bulk-Processed Post-Mortem Spinal Cord from ALS Patients and Normal Controls

  2025cites this paper
• Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases.

  2025cites this paper
• Novel approaches to EEG and MEG in motor neurone disease: IFCN Handbook Chapter

  2025cites this paper
• Mechanisms of neuromuscular junction dysfunction in amyotrophic lateral sclerosis

  2025cites this paper
• The Nucleolus and Its Associated Pathologies

  2025cites this paper
• Exosome Proteomics of SOD1D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker

  2025cites this paper
• Oxidative/Nitrosative Stress, Apoptosis, and Redox Signaling: Key Players in Neurodegenerative Diseases

  2025cites this paper
• Overexpression of HSP70 in mice with mutant FUS protein is accompanied by a mitigated neurodegeneration in limbic system

  2025cites this paper
• Adaptor‐Mediated Trafficking of Tank Binding Kinase 1 During Diverse Cellular Processes

  2025cites this paper
• Atypical forms of motor neuron disease: a review of the problem and clinical cases

  2025cites this paper
• Effects of virtual reality mindfulness on cognition and well-being in ALS: A randomized trial protocol.

  2025cites this paper
• Stratifying ALS Patients by Mode of Inheritance Reveals Transcriptomic Signatures Specific to sALS and fALS

  2025cites this paper
• Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review

  2024cites this paper
• The periprocedural respiratory safety of propofol sedation in patients with a motor neuron disease undergoing percutaneous endoscopic gastrostomy insertion.

  2024cites this paper
• Early signs of neurodegenerative diseases: Possible mechanisms and targets for Golgi stress.

  2024cites this paper
• Use of Muscle Ultrasonography in Morphofunctional Assessment of Amyotrophic Lateral Sclerosis (ALS)

  2024influential citation
• Thalamic Alterations in Motor Neuron Diseases: A Systematic Review of MRI Findings.

  2024cites this paper
• Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis

  2024cites this paper
• Emerging Evidence of Golgi Stress Signaling for Neuropathies

  2024cites this paper
• Traumatic injury causes selective degeneration and TDP-43 mislocalization in human iPSC-derived C9orf72-associated ALS/FTD motor neurons

  2024cites this paper
• Exploring SVA Insertion Polymorphisms in Shaping Differential Gene Expressions in the Central Nervous System

  2024cites this paper
• Amyloid-Induced Neurodegeneration: A Comprehensive Review through Aggregomics Perception of Proteins in Health and Pathology.

  2024cites this paper
• Neurofilament Light Chain Levels Interact with Neurodegenerative Patterns and Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis

  2024cites this paper
• Utilizing marine algal metabolites to fight neurodegenerative diseases

  2024cites this paper
• Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy

  2024cites this paper
• Delineating sex-dependent and anatomic decline of motor functions in the SOD1G93A mouse model of amyotrophic lateral sclerosis

  2024cites this paper
• Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis

  2024cites this paper
• Care Pathway Heterogeneity in Amyotrophic Lateral Sclerosis: Effects of Gender, Age, and Onset

  2024cites this paper
• Statistical analysis for the development of a deep learning model for classification of images with TDP-43 pathology

  2024influential citation
• Overview of nomenclature and diagnosis of amyotrophic lateral sclerosis

  2024cites this paper
• Modulation of the Receptor for Advanced Glycation End Products Pathway by Natural Polyphenols: A Therapeutic Approach to Neurodegenerative Diseases

  2024cites this paper
• Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation

  2024cites this paper
• Release of FUS into the extracellular space is regulated by its amino‐terminal prion‐like domain

  2024cites this paper
• Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging.

  2024cites this paper
• Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases

  2024cites this paper
• MicroRNA-219 in the central nervous system: a potential theranostic approach

  2024cites this paper
• BV2 Microglial Cell Activation/Polarization Is Influenced by Extracellular Vesicles Released from Mutated SOD1 NSC-34 Motoneuron-like Cells

  2024cites this paper
• Genetically modified non-human primate models for research on neurodegenerative diseases

  2024cites this paper
• Glycosylation in aging and neurodegenerative diseases

  2024cites this paper
• Programmed cell death and melatonin: A comprehensive review

  2024influential citation
• Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis.

  2024cites this paper
• Microstructural Changes in the Corpus Callosum in Neurodegenerative Diseases

  2024cites this paper